Others also demonstrated that ERα produced different activities during colon carcinogenesis, which could be dependent on the existence of several receptor splice forms, among which the ERα46 induced antiproliferative and apoptotic actions, whilst the shorter variant, ERα36, was promoted CRC progression [77]. The gene discussed is ESR1; the disease is colorectal carcinoma.